share_log

Market Snapshot | Three major indices closed higher, with the technology index up 0.15%; semiconductor stocks showed mixed performance, with Hua Hong Semiconductor down nearly 4% and Enno Silicon up nearly 2%; XPeng Motors surged nearly 18%, hitting a mor

Futu News ·  Nov 11 16:24

Futu News reported on November 11 that the three major Hong Kong stock indices all rose,$Hang Seng Index (800000.HK)$up 0.18%,$Hang Seng TECH Index (800700.HK)$up 0.15%, $Hang Seng China Enterprises Index (800100.HK)$up 0.19%.

At the close, 1,105 stocks in the Hong Kong market rose, 1,085 fell, and 1,033 remained unchanged.

The performance by specific industries is shown in the figure below:

In terms of sectors, technology and internet stocks showed mixed performance: Baidu Group-SW rose 2.31%, Alibaba-W dropped 1.84%, Xiaomi Group-W increased by 1.46%, Meituan-W declined by 1.26%, JD.com-SW fell by 1.12%, Kuaishou-W dropped 0.43%, and Tencent Holdings gained 0.08%.

Mixed performance in semiconductor stocks: Huahong Semiconductor fell 3.65%, FORTIOR dropped 3.12%, SMIC declined 2.74%, CEAC Tech rose 2.11%, Innoscience increased by 1.84%, Shanghai Fudan gained 1.44%, Ingdan Innovation fell 1.09%, and Baker Micro rose 0.70%.

The majority of new consumer concept stocks rose, with XPeng Motors surging nearly 18%, Laopu Gold rising over 2%, Nayuki's Tea gaining close to 2%, and Weilong Delicious increasing by more than 1%.

Hong Kong retail stocks performed strongly: Milan Station fell 6.54%, Samsonite rose 2.32%, Chow Tai Fook gained 2.02%, Prada increased by 1.68%, Sa Sa International grew 1.64%, Chow Sang Sang rose 1.56%, Lukfook Holdings climbed 0.90%, and Giordano International advanced 0.68%.

Property services and management stocks saw mixed results: Evergrande Property rose 4.51%, China Resources Mixc Lifestyle Services gained 3.88%, Sunac Services increased by 2.44%, Jinyi Group Holdings fell 1.82%, Poly Property climbed 1.43%, Vanke Cloud rose 1.12%, Country Garden Services gained 0.94%, and China Overseas Property advanced 0.60%.

Most coal stocks declined: China Qinfa rose 2.26%, Yanzhou Coal Mining fell 1.96%, China Coal Energy dropped 1.74%, Force Development gained 1.66%, China Shenhua declined 1.52%, MONGOL MINING fell 1.19%, and Shougang Resource rose 0.62%.

Real estate developers performed impressively: Poly Properties surged 7.61%, New World Development rose 2.76%, Longfor Group gained 2.15%, China Resources Land advanced 1.93%, Cheung Kong Property climbed 1.25%, Sunac China increased 0.70%, China Overseas Land & Investment rose 0.45%, and Henderson Land expanded 0.14%.

In terms of individual stocks,$XPENG-W (09868.HK)$The increase widened to nearly 18%, hitting a three-year high; institutions noted the initial emergence of an AI-driven embodied intelligence giant.

$SOFTCARE (02698.HK)$Dropped nearly 4% on the second day of listing, but still remained about 20% higher than the offering price.

$MOBVISTA (01860.HK)$Surged over 5%, with the overseas AI application leader posting better-than-expected third-quarter earnings. Institutions are optimistic about AI-driven efficiency improvements in the advertising business.

$REPT BATTERO (00666.HK)$Gains expanded by over 10%, driven by intensified policy support boosting high growth in the energy storage industry. The company benefits from the recovery in demand for energy storage batteries.

$CH INV FIN GP (01226.HK)$Surged over 28%, with interim net profit expected to exceed HKD 140 million, reversing a year-on-year loss to profitability.

$ASCLETIS-B (01672.HK)$Rose nearly 8% in late trading as ASC36 entered clinical development, with an IND application set to be filed in the second quarter of next year.

$CIG (06166.HK)$Dropped over 4%, following a gain of more than 7% in the previous trading session. The company expects the overall business performance in the fourth quarter to be positive.

$ZENERGY (03677.HK)$Rose nearly 3% in the afternoon session, with the potential for a MWh-scale all-solid-state battery pilot production line to commence operations in the first half of next year.

$YH ENT (02306.HK)$Fell nearly 7% again, drawing attention to the renewal issue involving Wang Yibo. The company's stock price has retreated by 40% from its high point earlier this year.

Top 10 in today's trading volume

Hong Kong Stock Connect funds

Regarding the Stock Connect program, today’s southbound trading under Hong Kong Stock Connect recorded a net inflow of HKD 4.467 billion.

Institutional Views

  • Morgan Stanley: Maintained an 'Overweight' rating for GDS Holdings, with promising growth potential expected for Day One.

Morgan Stanley issued a report stating that,$GDS-SW (09698.HK)$DayOne, the global data center operator of GDS Holdings, announced the development of Thailand's first 1GW data center campus. The plan includes the expansion of the Chonburi 1 campus and adjacent land, which will increase power capacity to 300MW, along with signing a memorandum of understanding with the Amata Group for the Chonburi 2 campus.

DayOne has also signed a renewable energy agreement to introduce solar power. Morgan Stanley holds a positive view on DayOne’s expansion plans, with relevant contracts expected to provide additional momentum. Recent developments indicate promising growth potential for DayOne. The firm maintains an 'Overweight' rating for GDS Holdings, with a target price of $54.

  • CMB International: CXO companies’ performance in the second half of the year is expected to recover, favoring firms like Guosheng Tang and Giant Biogene.

CMB International issued a research report stating that the MSCI China Healthcare Index has risen by 59.5% year-to-date, outperforming the MSCI China Index by 24%. However, the pharmaceutical sector has recently experienced a pullback, declining by approximately 10% since early October. The report notes that some stocks remain attractively valued and highlights its positive outlook on$3SBIO (01530.HK)$$GUSHENGTANG (02273.HK)$$GIANT BIOGENE (02367.HK)$$WUXI XDC (02268.HK)$$INNOVENT BIO (01801.HK)$and$SINO BIOPHARM (01177.HK)$, both with a 'Buy' rating.

The firm expects capital market financing activities to recover, with outbound transactions in innovative drugs expanding in scale. Domestic demand for innovative drug R&D is also anticipated to rebound, compounded by the U.S. entering an interest rate cut cycle. CXO companies’ performance in the second half of the year is forecasted to improve. The clinical development progress of already authorized innovative drug pipelines overseas is expected to become the most significant catalyst for the innovative drug sector.

  • Citi: Maintains November Macau gaming revenue forecast at MOP 20.5 billion.

Citi issued a research report stating that, according to industry surveys, Macau's gaming revenue for the first nine days of November was approximately MOP 6.4 billion, implying an average daily gaming revenue of about MOP 711 million. This figure is encouraging as November is seasonally a transitional month between the October Golden Week and the December holidays. The bank conservatively maintained its forecast for November gaming revenue at MOP 20.5 billion, which implies an estimated average daily gaming revenue of about MOP 671 million for the remainder of the month.

Editor/melody

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment